Cocrystal Pharma files corporate presentation; no material financial or operational details disclosed

Cocrystal Pharma, Inc.

Filing under Item 7.01 for an investor presentation dated January 13, 2025.
No earnings, clinical data, guidance changes, or other material facts included in the filing or exhibit.
Exhibit 99.1 attached but contains no extractable substantive content in the provided text.
Presentation was made to investment community; specific slide content not available for summary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.